Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 4, 1997, Pages 401-411

  Yenari, Midori A ^a   De Crespigny, Alexander ^a,b   Palmer, James T ^a   Roberts, Sarah ^a   Schrier, Stanley L ^a   Albers, Gregory W ^a   Moseley, Michael E ^a,b   Steinberg, Gary K ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diffusion weighted magnetic resonance imaging; Focal cerebral ischemia; Hirulog; Thrombolysis

Indexed keywords

ALTEPLASE; HIRULOG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; STROKE;

EID: 0030929323     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199704000-00005     Document Type: Article

References (66)

1. Agnelli G, Pascucci C, Cosmi B, Nenci GG (1991) Effects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits. Thromb Haemost 66:592-597
2. Altès A, Abellán MT, Mateo J, Avila A, Martí-Vilalta JL, Fontcuberta J (1995) Hemostatic disturbances in acute ischemic stroke: a study of 86 patients. Acta Haematol 94:10-15
3. Back T, Hoehn-Berlage M, Kohno K, Hossmann K-A (1994) Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. Stroke 25:494-500
4. Bednar MM, McAuliffe T, Raymond S, Gross CE (1990) Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. Stroke 21:1705-1709
5. Benes V, Zabramski JM, Boston M, Puca A, Spetzler RF (1990) Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits. Stroke 21:1594-1599
6. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632-640
7. Cannon CP, Braunwald E (1995) Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. J Am Coll Cardiol 25:30S-37S
8. Cannon CP, Maraganore JM, Loscalzo J, McAllister A, Eddings K, George D, Selwyn AP, Adelman B, Fox I, Braunwald E, Ganz P (1993) Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol 71:778-782
9. Carter LP, Guthkelch AN, Orozco J, Temeltas O (1992) Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model. Stroke 23:883-888
10. Chaitman BR, Thompson B, Wittry MD, Stump D, Hamilton WP, Hillis LD, Dwyer JG, Solomon RE, Knatterud GL (1989) The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from Thrombolysis in Myocardial Infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI investigators. J Am Coll Cardiol 14:1159-1165
11. Chehrazi BB, Seibert JA, Kissel P, Hein L, Brock JM (1989) Evaluation of recombinant tissue plasminogen activator in embolie stroke. Neurosurgery 24:355-360
12. de Crespigny AJ, Tsuura M, Moseley ME, Kucharczyk J (1993) Perfusion and diffusion MR imaging of thromboembolic stroke. J Magn Res Imag 3:746-754
13. del Zoppo GJ, Copeland BR, Anderchek K, Hacke W, Koziol JA (1990) Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke 21:596-601
14. Duke RJ, Bloch RF, Turpie AG, Trebilcock R, Bayer N (1986) Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 105:825-828
15. Fisher M, Francis R (1990) Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity. Arch Neurol 47:1075-1079
16. Fuchs J, Cannon CP (1995) Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation 92:727-733
17. GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682
18. GUSTO IIa Investigators (1994) Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa investigators. Circulation 90:1631-1637
19. GUSTO IIb Investigators (1996) Comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335:775-782
20. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M, for the ECASS Study Group (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025
21. Haley E Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marler JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC, for the TPA Bridging Study Group (1993) Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 24:1000-1004
22. Heras M, Chesebro JH, Webster MW, Mruk JS, Grill DE, Penny WJ, Bowie EJ, Badimon L, Fuster V (1990) Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation 82:1476-1484
23. Kanamasa K, Watanabe I, Cercek B, Yano J, Fishbein MC, Ganz W (1989) Selective decrease in lysis of old thrombi after rapid administration of tissue-type plasminogen activator. J Am Coll Cardiol 14:1359-1364
24. Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA (1991) Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 77:1006-1012
25. Klement P, Borm A, Hirsh J, Maraganore J, Wilson G, Weitz J (1992) The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model. Thromb Haemost 68:64-68
26. Knight RA, Dereski MO, Helpern JA, Ordidge RJ, Chopp M (1994) Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke 25:1252-1261
27. Kucharczyk J, Mintorovitch J, Moseley ME, Asgari HS, Sevick RJ, Derugin N, Norman D (1991) Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology 179:221-227
28. Kucharczyk J, Vexler ZS, Roberts TP, Asgari HS, Mintorovitch J, Derugin N, Watson AD, Moseley ME (1993) Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 188:711-717
29. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505
30. Levy DE, Brott TG, Haley E Jr, Marier JR, Sheppard GL, Barsan W, Broderick JP (1994) Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25:291-297
31. Little JR (1978) Modification of acute focal ischemia by treatment with mannitol. Stroke 9:4-9
32. Lo EH, Matsumoto K, Pierce AR, Garrido L, Luttinger D (1994) Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Metab 14:597-603
33. Lyden PD, Zivin JA, Clark WA, Madden K, Sasse KC, Mazzarella VA, Terry RD, Press GA (1989) Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology 39:703-708
34. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M (1992) Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 23:1304-1310
35. Minematsu K, Fisher M, Li L, Davis MA, Knapp AG, Cotter RE, McBurney RN, Sotak CH (1993) Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 43:397-403
36. +-ATPase activity. J Cereb Blood Flow Metab 14:332-336
37. Moliniari GF (1991) Thrombolytic therapy in ischemic stroke: relevance and limitations of animal models. In: Thrombolytic Therapy in Acute Ischemic Stroke (Hacke W, del Zoppo GJ, eds), New York, Springer-Verlag, pp 105-125
38. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J, Wendland MF, Weinstein PR (1990a) Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Res Med 14:330-346
39. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D (1990b) Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR 11:423-429
40. Muller TB, Haraldseth O, Jones RA, Sebastiani G, Godtliebsen F, Lindboe CF, Unsgard G (1995) Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion. Stroke 26: 451-457
41. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
42. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ (1994) Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 25:1847-1853
43. Overgaard K, Sereghy T, Boysen G, Pedersen H, Hoyer S, Diemer NH (1992a) A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 12:484-490
44. Overgaard K, Sereghy T, Pedersen H, Boysen G (1992b) Dose-response of rt-PA and its combination with aspirin in a rat embolie stroke model. Neuroreport 3:925-928
45. Overgaard K, Sereghy T, Pedersen H, Boysen G (1994) Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 14:472-477
46. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER (1988) Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood 72:616-620
47. Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC (1987) Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg 67:394-398
48. Rosen BR, Belliveau JW, Chien D (1989) Perfusion imaging by nuclear magnetic resonance. Magn Res Q 5:263-281
49. Russell D, Madden KP, Clark WM, Zivin JA (1992) Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration. Stroke 23:388-393
50. Steinberg GK, Gelb AW, Lam AM, Manninen PH, Peerless SJ, Rassi Neto A, Floyd P (1986) Correlation between somatosensory evoked potentials and neuronal ischemic changes following middle cerebral artery occlusion. Stroke 17:1193-1197
51. Steinberg GK, Saleh J, Kunis D, DeLaPaz R, Zarnegar SR (1989) Protective effect of N-methyl-d-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 20:1247-1252
52. Theroux P, Perez-Villa F, Waters D, Lesperance J, Shabani F, Bonan R (1995) Randomized double-blind comparison of two doses of hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction. Circulation 91:2132-2139
53. Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CJ, Zivin JA (1993) Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J Pharmacol Exp Ther 264:67-73
54. Thomas GR, Thibodeaux H, Errett CJ, Bednar MM, Gross CE, Bennett WF (1995) Intravenous aspirin causes a paradoxical attenuation of cerebrovascular thrombolysis. Stroke 26:1039-1046
55. TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med 320:618-627
56. Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakes DJ, Cohen M, Chapekis A, Gold HK, Tannenbaum MA, Rao AK, Debowey D, Schwartz D, Heris M, Chesebro J (1994) Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. Circulation 89:1557-1566
57. van den Bos AA, Deckers JW, Heyndrickx GR, Laarman GJ, Suryapranata H, Zijlstra F, Close P, Rijnierse JJ, Buller HR, Serruys PW (1993) Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation 88:2058-2066
58. von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23:646-652
59. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR (1995) Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37:231-241
60. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by anti-thrombin III-independent inhibitors. J Clin Invest 86:385-391
61. Yenari M, de Crespigny A, D'Arceuil H, Palmer J, Roberts S, Albers G, Schrier S, Moseley M, Steinberg G (1994a) Thrombolysis and diffusion MRI in a rabbit model of embolic stroke. Soc Neurosci Abst 20:180
62. Yenari M, de Crespigny A, D'Arceuil H, Yoshikawa J, Iwai K, Seri S, Palmer J, Roberts S, Steinberg G, Moseley M (1994b) Detection and characterization of cerebral ischemic lesions in a rabbit embolic stroke model. Proc Soc Magn Res 3:1373
63. Yenari M, de Crespigny A, D'Arceuil H, Palmer J, Roberts S, Yoshikawa J, Iwai K, Seri S, Steinberg G, Moseley M (1995a) Magnetic resonance perfusion imaging in a rabbit embolic stroke model. J Cereb Blood Flow Metab 15:S364
64. Yenari MA, Palmer JT, Bracci PM, Steinberg GK (1995b) Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res 77:475-481
65. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289-1292
66. Zivin JA, Lyden PD, DeGirolami U, Kochhar A, Mazzarella V, Hemenway CC, Johnston P (1988) Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol 45:387-391